Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
glimepiride (amaryl) (1 trial)
saxagliptin (onglyza) (1 trial)
dexamethasone (2 trials)
pomalidomide (pomalyst) (1 trial)
abiraterone (zytiga) (1 trial)
bicalutamide (casodex) (1 trial)
blinatumomab (blincyto) (1 trial)
cobalamin (1 trial)
folic acid (1 trial)
pemetrexed (alimta) (2 trials)
prednisone (meticorten) (2 trials)
anti-cd33 car-nk cells (1 trial)
hs-10360 (1 trial)
interferon gamma-1b (actimmune) (1 trial)
pembrolizumab (keytruda) (1 trial)
qing'e (1 trial)
rt-01 (2 trials)
acetylsalicylic acid (aspirin) (1 trial)
bifidobacterium longum (1 trial)
dalteparin (fragmin) (1 trial)
empagliflozin (jardiance) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
linagliptin (tradjenta) (1 trial)
liraglutide (victoza) (1 trial)
Breast Neoplasms (Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Trials (16 total)
Trial APIs (24 total)